A detailed history of Edentree Asset Management LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Edentree Asset Management LTD holds 43,325 shares of EXAS stock, worth $2.31 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
43,325
Previous 43,325 -0.0%
Holding current value
$2.31 Million
Previous $2.99 Billion 38.86%
% of portfolio
0.58%
Previous 0.95%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $16,485 - $24,760
250 Added 0.58%
43,325 $2.95 Billion
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $2.7 Million - $4.09 Million
43,075 New
43,075 $4.04 Billion

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.42B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Edentree Asset Management LTD Portfolio

Follow Edentree Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edentree Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Edentree Asset Management LTD with notifications on news.